Current Report Filing (8-k)
June 13 2022 - 04:32PM
Edgar (US Regulatory)
Inogen
Incfalse000129413300012941332022-06-082022-06-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
Date of Report (Date of earliest event reported):
June 08, 2022
|
INOGEN, INC.
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
Delaware
|
001-36309
|
33-0989359
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
301 Coromar Drive
|
|
|
Goleta,
California
|
|
93117
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
Registrant’s Telephone Number, Including Area Code:
(805)
562-0500
|
(Former Name or Former Address, if Changed Since Last
Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value
|
|
INGN
|
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 5.07 Submission of Matters to a Vote of Security
Holders.
Inogen, Inc. (the “Company”) held its 2022 annual meeting of
stockholders on June 8, 2022 (the “Annual Meeting”). Of the
22,835,794 shares of the Company’s common stock outstanding as of
the record date of April 11, 2022, 20,595,021 shares were
represented at the Annual Meeting, either by proxy or by attending
the meeting, constituting approximately 90.18% of the outstanding
shares of common stock. The matters voted on at the Annual Meeting
and the votes cast with respect to each such matter are set forth
below:
1.
Election of Class II Directors.
The following nominees were elected to serve as Class II directors,
to hold office until the Company’s 2025 annual meeting of
stockholders or until his or her respective successor has been duly
elected and qualified:
|
|
|
|
|
|
|
|
Nominee
|
|
Votes For
|
|
Votes Withheld
|
|
Broker Non-Votes
|
|
Kevin King
|
|
19,195,244
|
|
114,388
|
|
1,285,389
|
|
Mary Kay Ladone
|
|
19,195,296
|
|
114,336
|
|
1,285,389
|
|
Nabil Shabshab
|
|
14,647,832
|
|
4,661,800
|
|
1,285,389
|
2.
Ratification of Appointment of Independent Registered Public
Accounting Firm.
The appointment of Deloitte & Touche LLP as the Company’s
independent registered public accounting firm for the fiscal year
ending December 31, 2022 was ratified based on the following
results of voting:
|
|
|
|
|
|
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
|
20,562,878
|
|
8,721
|
|
23,422
|
|
—
|
3.
Advisory Vote on Executive Compensation.
The Company’s stockholders advised that they were in favor of the
named executive officers’ compensation as disclosed in the proxy
statement. The votes regarding the proposal were as
follows:
|
|
|
|
|
|
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
|
18,392,222
|
|
885,879
|
|
31,531
|
|
1,285,389
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
INOGEN, INC.
|
|
|
|
|
|
|
Date:
|
June 13, 2022
|
By:
|
/s/ Kristin Caltrider
|
|
|
|
|
Kristin Caltrider
Executive Vice President
Chief Financial Officer
Treasurer
(Principal Accounting and Financial Officer)
|
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Nov 2022 to Dec 2022
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Dec 2021 to Dec 2022
